https://www.selleckchem.com/pr....oducts/Vorinostat-sa
9%). Teicoplanin with ertapenem was the most common regimen selected for combination therapy (n=9, 52.9%). A total of 23 episodes (17.4%) resulted in a readmission, 6 (30%) of which were because of patient deterioration. The mean service running weekly cost was €455.47/$538.68 and a total of 3287 days of hospital stay were avoided. This effectively illustrates that the OPAT service optimised hospital bed availability without compromising care delivery. The national OPAT service proved to be a safe and effective alternative for p
Beğen
Yorum Yap
Paylaş
